<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pharmateca</journal-id><journal-title-group><journal-title xml:lang="en">Pharmateca</journal-title><trans-title-group xml:lang="ru"><trans-title>Фарматека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-4034</issn><issn publication-format="electronic">2414-9128</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">278828</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">NUROFEN IN THE TREATMENT OF FEVER, PAIN, AND FERVESCENCE</article-title><trans-title-group xml:lang="ru"><trans-title>НУРОФЕН В ЛЕЧЕНИИ ЛИХОРАДКИ, БОЛИ, ЖАРА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Erofeeva</surname><given-names>Svetlana Borisovna</given-names></name><name xml:lang="ru"><surname>Ерофеева</surname><given-names>Светлана Борисовна</given-names></name></name-alternatives><bio xml:lang="ru"><p>ГКБ № 61, Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Yerofeyeva</surname><given-names>S B</given-names></name><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГКБ № 61, Москва</institution></aff></aff-alternatives><aff id="aff2"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2011-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2011</year></pub-date><volume>18</volume><issue>5</issue><issue-title xml:lang="en">NO5 (2011)</issue-title><issue-title xml:lang="ru">№5 (2011)</issue-title><fpage>56</fpage><lpage>61</lpage><history><date date-type="received" iso-8601-date="2023-02-23"><day>23</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, ООО «Бионика Медиа»</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2073-4034/article/view/278828">https://journals.eco-vector.com/2073-4034/article/view/278828</self-uri><abstract xml:lang="en"><p>Ibuprofen is derivative of propionic acid and belongs to a group of nonsteroidal anti-inflammatory drugs (NSAIDs). Despite the significantly increase of number of NSAID in recent years, ibuprofen is the drug of choice for treatment of pain and fever, especially in pediatric practice.</p></abstract><trans-abstract xml:lang="ru"><p>Ибупрофен относится к группе нестероидных противовоспалительных средств (НПВС), являясь производным пропионовой кислоты. Несмотря на то что за последние годы количество НПВС значительно возросло, ибупрофен остается препаратом выбора для лечения боли и лихорадки, особенно в педиатрической практике.</p></trans-abstract><kwd-group xml:lang="en"><kwd>nonsteroidal anti-inflammatory drugs</kwd><kwd>ibuprofen</kwd><kwd>Nurofen</kwd><kwd>fever</kwd><kwd>inflammation</kwd><kwd>pain</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нестероидные противовоспалительные средства</kwd><kwd>ибупрофен</kwd><kwd>Нурофен</kwd><kwd>лихорадка</kwd><kwd>воспаление</kwd><kwd>боль</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>История открытия ибупрофена. http://ru.wikipedia.org</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Геппе Н.А. Эффективность и безопасность ибупрофена при лихорадке у детей // Consilium medicum 2003. Т. 5. № 9.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Carol AR, et al. Cyclooxygenases: structural and functional insights. J Lipid Res 2009;50:29-34.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Marnett LJ, Kalgutkar AS. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci 1999;20:465-69.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Creyer B, Feldman N. Cyclo-oxygenase-1 and cyclo-oxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998;104:413-21.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Rainsford KD. Ibuprofen:pharmacology,efficacy and safety. Inflammopharmacology 2009;17(6):275-342</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Paik JH, Ju JH, Lee JY, et al. Two opposing effects of non steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways. J Biol Chem 2000;275:28173-79.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Miranda HF, Sierralta F, Pinardi G. Neostigmine interactions with non steroidal anti-inflammatory drugs. Br J Pharmacol 2002;135(7):1591-97.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Тринус Ф.П., Бухтиарова Т.А. Фармакологический анализ участия моноаминергических систем в механизме анальгезирующего действия НПВП // Фармакология и токсикология 1989. Т. 24. С. 89-92.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Drugs of choice from the Medical Letter. New York. Revised ed. 1995.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Moore IN, Ganse EV, Le Pare JM, et al. The PAIN Study: paracetamol, aspirine and ibuprofen new tolerability study. A large scale, randomized clinical trial comparing the tolerability of aspirine, ibu-profen and paracetamol for short-term analgesia. Clin Drug Invest 1999;18(2):88-98.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Вейн А.М., Табеева Г.Р. Применение Нурофена в неврологической клинике // Журнал неврологии и психиатрии им. С.С. Корсакова 1998. № 4. С. 25-28.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Codispoti JR, Prior MJ, Fu M, et al. Efficacy of nonprescription doses of ibuprofen for treating migraine headache: a randomized controlled trial. Headache 2001;41:665-79.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Nebe J, Heier M, Diener HC. Low-dose ibuprofen is self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo. Cephalalgia 1995;15:531.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Welker Y, et al. Multicentre, GP based study of the antipyretic activity and the tolerance of ibuprofen in the treatment of febrile syndromes in adults. Med Mal Infect 1998.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Walson PD, et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children. Clin Pharmacol Ther 1989;46:9-17.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Lesko SM, Mitchell AA. An assessment of the safety of paediatric ibuprofen: A practitioner-based randomized clinical trial. J Am Med Association 1995;273:929-33.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Henry D, Lim LL, Rodrigues LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of collaborative meta-analysis. BMJ 1996;312:1563.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Brown RD, et al. Single dose pharmacokinetics of ibuprofen and acetaminophen in febrile children. J Clin Pharmacol 1992;32:231-4.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Hernandez-Diaz S, Varas-Lorenzo C, Garcia Rodriguez LA. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol 2006;98(3):266-74.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Trelle S, at al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011;342:7086.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Lesko SM, Mitchell AA. An assessment of the safety of paediatric ibuprofen: A practitioner-based randomized clinical trial. J Am Med Association 1995;273:929-33.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin 2009;25(9):2207-22.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Bookstaver PB, Miller AD, Rudisill CN, et al. Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. J Pain Res 2010;25;3:67-79.</mixed-citation></ref></ref-list></back></article>
